Genetic factors affecting the consistency and magnitude of changes in plasma cholesterol in response to dietary challenge

QJM: An International Journal of Medicine

Volumn 89, Issue 9, 1996, Pages 671-680

  Humphries, S E ^a   Talmud, P J ^a   Cox, C ^b   Sutherland, W ^b   Mann, J ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN C3; CHOLESTEROL; LIPOPROTEIN LIPASE; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SIGNAL PEPTIDE;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; DNA DETERMINATION; FAT INTAKE; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0029757287     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.9.671     Document Type: Article

References (58)

1. Hegsted D, McGrandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965; 17:281-95.
2. McNamara DJ, Kolb R, Parker TS, et al. Heterogeneity of cholesterol homeostasis in man: Response to changes in dietary fat quality and cholesterol quantity. J Clin Invest 1987; 79:1729-39.
3. Keys A, Anderson JT, Grande F. Prediction of serum cholesterol responses of man to changes in fats in the diet. Lancet 1957; 2:959-66.
4. Keys A, Anderson JT, Grande F. Serum cholesterol in man: Diet fat and intrinsic responsiveness. Circulation 1959; 19:201-14.
5. Grundy SM, Vega GL. Plasma cholesterol responsiveness to saturated fatty acids. Am J Clin Nutr 1988; 47:822-4.
6. Katan MB, Berns MA, Glatz JF, Knuiman JT, Nobels A. Congruence of individual responsiveness to dietary cholesterol and saturated fats in humans. J Lipid Res 1988; 29:883-92.
7. Keys A, Anderson JT, Grande F. Serum cholesterol responses to changes in the diet IV. Particular saturated fatty acids in the diet. Metabolism 1965; 14:776-87.
8. Clifton PM, Nestel PJ. Influence of gender, body mass index, and age on response of plasma lipids to dietary fat plus cholesterol. Arterioscler Thromb 1992; 3:349-56.
9. Jacobs DR, Anderson JT, Hanan P, Keys A, Blackburn H. Variability in individual serum cholesterol response to change in diet. Arteriosclerosis 1983; 349-56.
10. Katan MB, De Vries JH, Nobels A. Existence of consistent hypo- and hyper-responders to dietary cholesterol in man. Am J Epidemiol 1986; 123:221-34.
11. Abbey M. The influence of apolipoprotein polymorphism on the response to dietary fat and cholesterol. Curr Opin Lipidol 1992; 3:12-16.
12. 4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 1990; 10:285-8.
13. Clifton PM, Kestin M, Abbey M, Drysdale M, Nestel PJ. Relationship between sensitivity to dietary fat and dietary cholesterol. Arteriosclerosis 1990; 10:394-40.
14. Mänttäri M, Koskinen P, Ehnholm C, Huttunen JK, Manninen V. Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 1991; 40:217-21.
15. Kesaniemi YA, Ehnholm C, Miettinen TA. Intestinal absorbtion efficiency in man is related to apoprotein E phenotype. J Clin Invest 1987; 80:578-81.
16. Ehnholm C, Huttunen JK, Pietinen P, Leino U, Mutanen M, Kostianen E, Pikkararainen J, Dougherty R, Iancono J, Puska P. Effect of diet on serum lipoproteins in a population with a high risk of coronary heart disease. N Engl J Med 1982; 307:850-5.
17. Xu C-F, Tikkanen MJ, Huttunen JK, Pietinen P, Butler R, Humphries S, Talmud P. Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. J Lipid Res 1990a; 31:1255-61.
18. Tikkanen MJ, Xu F, Hämäläinen T, Talmud P, Sarna S, Huttunen JK, Pietinen P, Humphries S. Xbal polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin Gent 1990; 37:327-34.
19. Xu C-F, Boerwinkle E, Tikkanen MJ, Huttunen JK, Humphries SE. Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genetic Epidemiology 1990b; 7:261-75.
20. Boerwinkle E, Brown SA, Rohrbach K, Gotto Jr AM, Patsch W. Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am J Hum Genet 1991; 49:1145-54.
21. Abbey M, Belling B, Clifton P, Nestel P. Apolipoprotein B gene polymorphism associates with plasma cholesterol changes induced by dietary fat and cholesterol. Nutr Metab Cardiovasc Dis 1991; 1:10-12.
22. Xu C-F, Angelico F, Del Ben AM, Pannozzo F, Mazzarella B, Miller NE, Humphries SE, Talmud PJ. Polymorphisms at the apolipoprotein loci and response of plasma lipids to dietary change in Italian children. Nutr Metab Cardiovasc Dis 1992; 2:26-32.
23. Freidlander Y, Kaufmann NA, Cedar H, Kark JD. Xbal polymorphism of the apolipoprotein B gene and plasma lipid and lipoprotein response to dietary fat and cholesterol: a clinical trial. Clin Genet 1993a; 43:223-31.
24. Renges H-H, Wile DB, McKeigue P, Marmot MG, Humphries SE. Apo B gene polymorphisms are associated with lipid levels in individuals of South Asian descent. Atherosclerosis 1991; 91:267-75.
25. Hixson JE, McMahan A, McGill Jr HC, Strong JP, PDAY Research Group. Apolipoprotein B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Arterioscler Thromb 1992; 12:1023-7.
26. Peacock R, Dunning A, Hamsten A, Tornvall P, Humphries S, Talmud P. Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 1992; 92:151-62.
27. Visvikis S, Cambou JP, Arveiler D, Evans AE, Parra HJ, Aguillon D, Fruchart JC, Siest C, Cambien F. Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls: 'The ECTIM Study'. Hum Genet 1993; 90:561-5.
28. Xu C-F, Talmud P, Schuster H, Houlston R, Miller G, Humphries S. The association between genetic variation at the apo AI-CIII-AIV gene cluster and familial combined hyperlipidaemia. Clin Genet 1994; 46:385-97.
29. Peacock RE, Hamsten A, Johansson J, Nilsson-Ehle P, Humphries SE. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Clin Genet 1994; 46:273-82.
30. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989; 79:85-91.
31. Thorn JA, Chamberlain JC, Alcolado JC, Oka K, Chan L, Stocks J, Gallon DJ. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 1990; 85:55-60.
32. Heizmann C, Kirchgessner T, Kwiterovich PO, Ladias JA, Derby C, Antonarakis SE, Lusis AJ. DNA polymorphisms haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet 1991; 86:578-84.
33. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992; 97:171-85.
34. Peacock RE, Watts GF, Mandalia S, Brunt J, Lewis B, Humphries SE. Associations between genotypes of the apolipoprotein E, B, AI-CIII-AIV and lipoprotein lipase genes and coronary artery disease in the St Thomas' Atherosclerosis Regression Study. Nutr Metab Cardiovasc Dis 1994; 4:128-36.
35. Cox C, Mann J, Sutherland W, Ball M. Individual variation in plasma cholesterol response to dietary saturated fat. Br Med J 1995; 311:1260-4.
36. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1989; 16:1215.
37. Berg K. Predictive genetic testing to control coronary heart disease and hyperlipidaemia. Arteriosclerosis Supplement I 1989; 9:51-8.
38. Pullinger CR, North JD, Teng B-B, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res 30:1065-77.
39. Dixon JL, Ginsberg HN. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells, J Lipid Res 1993; 34:167-79.
40. White AL, Graham DL, LeGros J, Pease RJ, Scott J. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. J Biol Chem 1992; 267:15 657-64.
41. Dixon JL, Furukawa S, Ginsberg HN. Oleate stimulates secretion of apolipoprotein-B-containing lipoproteins from HepG2 cells by inhibiting early intracellular degradation of apolipoprotein B. J Biol Chem 1991; 266:5080-4.
42. Sturley SL, Talmud PJ, Brasseur R, Culbertson MR, Humphries SE, Attie AD. Human apolipoprotein B signal sequence variants confer a secretion defective phenotype when expressed in yeast. J Biol Chem 1994; 269:21 670-6.
43. Peacock RE, Karpe F, Talmud PJ, Hamsten A, Humphries SE. Common variation in the gene for apolipoprotein B modulates postprandial lipoprotein metabolism: an hypothesis generating study. Atherosclerosis 1995; 116:135-45.
44. Paul-Hayase H, Rosseneu M, Robinson D, Van Bervliet JP, Deslypere JP, Humphries SE. Polymorphisms in the apolipoprotein (apo) AI-CII-AIV gene cluster: detection of genetic variation determining plasma apo AI, Apo CIII and Apo AIV concentrations. Hum Genet 1992; 88:439-46.
45. Shoulders CC, Ball MJ, Mann JI, Baralle FE. Genetic marker in apolipoprotein AI/CIII gene complex associated with hypercholesterolaemia. Lancet 1986; ii:1286-8.
46. Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, Gilligan M, Gambert P, Ball MJ. Variation at the apo AI-CIII-AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 1991; 87:239-47.
47. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apolipoprotein A-1 gene: relation to hypertriglyceridaemia. Lancet 1983; i:444-6.
48. Hayden MR, Kirk H, Clark C, Frohlich J, Rabkin S, McLeod R, Hewitt J. DNA polymorphisms in and around the apoAI-CIII genes and genetic hyperlipidaemias. Am J Hum Genet 1987; 40:421-30.
49. Eisenberg S. High density lipoprotein metabolism, J Lipid Res 1987; 25:1017-57.
50. Brown WV, Baginsky ML. Inhibition of lipoprotein lipase by an apolipoprotein of human very low density lipoprotein. Biochem Biophys Res Commun 1972; 46:375-82.
51. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins: Effect of apolipoprotein CIII. J Clin Invest 1985; 75:384-90.
52. Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown VW. Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein CIII and AI: Evidence that apolipoprotein CIII inhibits catabolism of triglyceride rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 1986; 8:1287-95.
53. Windier E, Havel RJ. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J Lipid Res 1985; 26:556-65.
54. Ito Y, Azrolan N, O'Connell A, Walsh A, Breslow JL. Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 1990; 249:790-3.
55. Aalto-Setälä K, Fisher EA, Chen X, Shaul TC, Hayek T, Zechner R, Walsh A, Ramakrishnan R, Ginsberg H, Breslow JL. Mechanism of hypertriglyceridemia in human apolipoprotein CIII transgenic mice. J Clin Invest 1992; 90:1889-900.
56. O'Connell A, Walsh A, Azrolan N, Breslow JL. Intestinal expression of human apo A-I and apo C-III in transgenic mice. Arteriosclerosis 1990; 10:773a.
57. Beisiegel U, Weber W, Bengtsson-Olivecrona G. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc Natl Acad Sci USA 1991; 88:8342-8.
58. Williams KJ, Petrie KA, Brocia RW, Swenson TL. LPL modulates net secretory output of ApoB in vitro. J Clin Invest 1991; 88:1300-7.